L.G. Hansen Carl's most recent trade in AbCellera Biologics Inc was a trade of 2,730,109 Share option (right to buy) done . Disclosure was reported to the exchange on Jan. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 2,730,109 | 10,990,332 | - | - | Share option (right to buy) | |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2024 | 56,125 | 8,260,223 | - | - | Share option (right to buy) | |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.70 per share. | 25 Nov 2024 | 56,125 | 898,000 | - | 2.7 | 151,538 | Common Shares |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Sep 2024 | 56,125 | 8,316,348 | - | - | Share option (right to buy) | |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.70 per share. | 20 Sep 2024 | 56,125 | 841,875 | - | 2.7 | 151,538 | Common Shares |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.70 per share. | 31 May 2024 | 56,125 | 785,750 | - | 2.7 | 151,538 | Common Shares |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 56,125 | 8,372,473 | - | - | Share option (right to buy) | |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.70 per share. | 26 Feb 2024 | 56,125 | 729,625 | - | 2.7 | 151,538 | Common Shares |
| AbCellera Biologics Inc | Carl Hansen L.G. | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 56,125 | 8,428,598 | - | - | Share option (right to buy) | |
| AbCellera Biologics Inc | L.G. Hansen Carl | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2024 | 2,095,532 | 8,484,723 | - | - | Share option (right to buy) | |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.70 per share. | 24 Aug 2023 | 56,125 | 617,375 | - | 2.7 | 151,538 | Common Shares |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2023 | 56,125 | 6,445,316 | - | - | Share option (right to buy) | |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2023 | 56,125 | 6,501,441 | - | - | Share option (right to buy) | |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.70 per share. | 26 May 2023 | 56,125 | 561,250 | - | 2.7 | 151,538 | Common Shares |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2023 | 56,125 | 6,557,566 | - | - | Share option (right to buy) | |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.70 per share. | 22 Feb 2023 | 56,125 | 505,125 | - | 2.7 | 151,538 | Common Shares |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2022 | 925,069 | 6,613,691 | - | - | Share Options (right to buy) | |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2022 | 56,125 | 5,688,622 | - | - | Share option (right to buy) | |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.70 per share. | 18 Nov 2022 | 56,125 | 449,000 | - | 2.7 | 151,538 | Common Shares |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2022 | 56,125 | 5,744,747 | - | - | Share option (right to buy) | |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.70 per share. | 18 Aug 2022 | 56,125 | 392,875 | - | 2.7 | 151,538 | Common Shares |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.70 per share. | 18 May 2022 | 56,125 | 336,750 | - | 2.7 | 151,538 | Common Shares |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 56,125 | 5,800,872 | - | - | Share option (right to buy) | |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 56,125 | 5,856,997 | - | - | Share option (right to buy) | |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.70 per share. | 22 Feb 2022 | 56,125 | 280,625 | - | 2.7 | 151,538 | Common Shares |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2021 | 920,312 | 5,913,122 | - | - | Share Option (right to buy) | |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2021 | 224,500 | 4,992,810 | - | - | Share option (right to buy) | |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.03 per share. | 18 Nov 2021 | 224,500 | 224,500 | - | 15.0 | 3,374,235 | Common Shares |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 24.03 per share. | 09 Jun 2021 | 5,598,420 | 55,604,330 | - | 24.0 | 134,530,033 | Common Shares |
| AbCellera Biologics Inc | Carl L.G. Hansen | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 25.50 per share. | 09 Jun 2021 | 401,580 | 233,500 | - | 25.5 | 10,240,290 | Common Shares |